The study began in February 2004, with its primary completion and estimated completion dates not specified. The last update was submitted on June 30, 2025. These dates are crucial as they indicate the ...

The intervention tested is the Medtronic AT500, a device designed to prevent and terminate AT episodes in patients with conventional pacemaker needs. This device is intended to improve patient ...

Medtronic's growth strategies, dividend stability, and innovation focus amidst debt concerns and market risks. Click here to ...

The uptick in the historic period can be linked to an increased preference for home-based cardiac monitoring, an enhancement in the number of cardiac surgeries and implantations, a burgeoning demand ...

By Amruta Khandekar (Reuters) – Steady sales of pacemakers and heart stents may have likely helped Medtronic Plc offset weak demand for its other medical devices, in a quarter that saw an ...

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter ...

Analysts have recently evaluated Medtronic and provided 12-month price targets. The average target is $95.25, accompanied by a high estimate of $101.00 and a low estimate of $90.00. Observing a ...

NEW YORK CITY -- The newer Navitor looked increasingly viable as a transcatheter aortic valve replacement (TAVR) system, ...

The first-ever pacemaker to include Managed Ventricular Pacing (MVP®), the EnRhythm™ Pacing System promotes intrinsic conduction and is clinically proven to significantly reduce unnecessary ...

Here at the New York Valves meeting, hosted by the Cardiovascular Research Foundation, panelists mulled over the options: ...

Medtronic has just launched new MRI-compatible polyurethane-coated, thinner-tined leads, which may prompt more widespread and safe use of MRI conditional systems.